In conclusion, decreased FGF19 in a pig model of pediatric NAFLD was associated with increased CYP8B1 expression in the liver and an increased CA to CDCA ratio in the enterohepatic BA pool. This evidence concerns the gene FGF19 and metabolic dysfunction-associated steatotic liver disease.